Microarray profiling of HepG2 cells ectopically expressing NDRG2
Xuewu Liu1, Tianshui Niu, Xingping Liu
1Department of Biochemistry and Molecular Biology, The Fourth Military Medical University, Xi'an, People's Republic of China.
Abstract:
Previous studies have demonstrated that N-Myc downstream-regulated gene 2 (NDRG2) is a tumor suppressor that is downregulated in many human cancers and when overexpressed, can inhibit tumor growth and metastasis. However, its molecular function, its modulatory targets, and signaling pathways associated with it remain unclear. Here, in an effort to identify the genes modulated by NDRG2 expression, a microarray study was conducted to detect the expression profile of HepG2 cells overexpressing NDRG2 or LacZ. Gene Ontology (GO) biological process analysis revealed that genes related to G protein signaling pathway were upregulated. Five of them were selected and verified by real-time PCR. Gene sets related to M phase of cell cycle were downregulated. This was in agreement with cell cycle analysis. Signaling pathway analysis demonstrated apparent augmented hematopoietic cell lineage pathway and cell adhesion, but reduced glycosylphosphatidylinositol (GPI)-anchor biosynthesis, protein degradation and SNARE interactions. Furthermore, through motif analysis and experimental validation, we found that the p38 phosphorylation can be increased by NDRG2. Our research provides the molecular basis for understanding the role of NDRG2 in tumor cells and raises interesting questions about its mechanisms and potential use in cancer therapy.
Insights
N-Myc downstream-regulated gene 2 (NDRG2) acts as a tumor suppressor. Overexpressing NDRG2 influences G protein signaling, cell cycle, and cell adhesion, offering potential for cancer therapy.
Area of Science:
- Molecular Biology
- Cancer Research
- Genomics
Background:
- N-Myc downstream-regulated gene 2 (NDRG2) is a known tumor suppressor.
- NDRG2 is frequently downregulated in human cancers.
- The precise molecular functions and targets of NDRG2 are not fully understood.
Purpose of the Study:
- To identify genes modulated by NDRG2 expression.
- To elucidate the molecular mechanisms and signaling pathways affected by NDRG2.
- To explore the potential of NDRG2 in cancer therapy.
Main Methods:
- Microarray analysis of HepG2 cells overexpressing NDRG2 or LacZ.
- Gene Ontology (GO) analysis for biological processes.
- Real-time PCR for gene expression verification.
- Cell cycle analysis.
- Signaling pathway analysis.
- Motif analysis and experimental validation.
Main Results:
- NDRG2 overexpression upregulated genes in the G protein signaling pathway.
- Genes associated with the M phase of the cell cycle were downregulated, consistent with cell cycle analysis.
- Signaling pathway analysis revealed increased hematopoietic cell lineage and cell adhesion pathways.
- Decreased pathways included glycosylphosphatidylinositol (GPI)-anchor biosynthesis, protein degradation, and SNARE interactions.
- NDRG2 was found to increase p38 phosphorylation.
Conclusions:
- NDRG2 influences multiple cellular processes, including G protein signaling, cell cycle progression, and cell adhesion.
- NDRG2 impacts key signaling pathways relevant to cancer.
- NDRG2 enhances p38 phosphorylation, suggesting a role in cellular stress response or signaling.
- This study provides a molecular basis for understanding NDRG2's tumor-suppressive role and its therapeutic potential in cancer.
